Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bollschweiler

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Oncology Letters|June 29, 2012
The prognostic impact of extracapsular lymph node involvement in rectal cancer patients: Implications for staging and adjuvant treatment strategiesJ Brabender, E Bollschweiler, A H Hölscher, et al.
Annals of Surgery|November 2, 2010
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancerD Vallböhmer, Arnulf H Hölscher, S DeMeester, et al.
Histology and Histopathology|May 24, 2008
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancerH Alakus, G Grass, J K Hennecken, et al.
Journal of Surgical Oncology|July 22, 2010
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancerD Vallböhmer, A H Hölscher, P M Schneider, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 2, 2017
Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched studyF Favi, E Bollschweiler, F Berlth, et al.
The International Journal of Biological Markers|October 3, 2006
Is the urokinase-type plasminogen activator system a reliable prognostic factor in gastric cancer?T Luebke, S E Baldus, D Spieker, et al.
The Pharmacogenomics Journal|March 11, 2009
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancerH Alakus, U Warnecke-Eberz, E Bollschweiler, et al.
Histopathology|January 16, 2007
Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancerF C Ling, S E Baldus, J Khochfar, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 25, 2003
[Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies]E Bollschweiler, P M Schneider, S P Mönig, et al.
World Journal of Surgery|December 29, 2017
Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-GastrectomyFelix Berlth, K Messerle, P S Plum, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Oncology Letters|June 29, 2012
The prognostic impact of extracapsular lymph node involvement in rectal cancer patients: Implications for staging and adjuvant treatment strategiesJ Brabender, E Bollschweiler, A H Hölscher, et al.
Annals of Surgery|November 2, 2010
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancerD Vallböhmer, Arnulf H Hölscher, S DeMeester, et al.
Histology and Histopathology|May 24, 2008
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancerH Alakus, G Grass, J K Hennecken, et al.
Journal of Surgical Oncology|July 22, 2010
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancerD Vallböhmer, A H Hölscher, P M Schneider, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 2, 2017
Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched studyF Favi, E Bollschweiler, F Berlth, et al.
The International Journal of Biological Markers|October 3, 2006
Is the urokinase-type plasminogen activator system a reliable prognostic factor in gastric cancer?T Luebke, S E Baldus, D Spieker, et al.
The Pharmacogenomics Journal|March 11, 2009
GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancerH Alakus, U Warnecke-Eberz, E Bollschweiler, et al.
Histopathology|January 16, 2007
Association of COX-2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancerF C Ling, S E Baldus, J Khochfar, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|February 25, 2003
[Prognostic relevance of biological and molecular markers in oncology. Criteria for planning and interpreting studies]E Bollschweiler, P M Schneider, S P Mönig, et al.
World Journal of Surgery|December 29, 2017
Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-GastrectomyFelix Berlth, K Messerle, P S Plum, et al.
Pageof 9